Neoleukin Therapeutics Probability of Future Stock Price Finishing Over 0.66
NLTXDelisted Stock | USD 0.69 0.01 1.43% |
Neoleukin |
Neoleukin Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neoleukin Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neoleukin Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Neoleukin Therapeutics is now traded under the symbol NGNE. Please update your portfolios or report it if you believe this is an error. Report It! | |
Neoleukin Therapeutics is not yet fully synchronised with the market data | |
Neoleukin Therapeutics has some characteristics of a very speculative penny stock | |
Neoleukin Therapeutics has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (57.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Neoleukin Therapeutics currently holds about 116.46 M in cash with (45.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 16.0% of the company outstanding shares are owned by corporate insiders |
Neoleukin Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neoleukin Stock often depends not only on the future outlook of the current and potential Neoleukin Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neoleukin Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 55.2 M | |
Cash And Short Term Investments | 96.4 M |
Neoleukin Therapeutics Technical Analysis
Neoleukin Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Neoleukin Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neoleukin Therapeutics. In general, you should focus on analyzing Neoleukin Stock price patterns and their correlations with different microeconomic environments and drivers.
Neoleukin Therapeutics Predictive Forecast Models
Neoleukin Therapeutics' time-series forecasting models is one of many Neoleukin Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Neoleukin Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Neoleukin Therapeutics
Checking the ongoing alerts about Neoleukin Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Neoleukin Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neoleukin Therapeutics is now traded under the symbol NGNE. Please update your portfolios or report it if you believe this is an error. Report It! | |
Neoleukin Therapeutics is not yet fully synchronised with the market data | |
Neoleukin Therapeutics has some characteristics of a very speculative penny stock | |
Neoleukin Therapeutics has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (57.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Neoleukin Therapeutics currently holds about 116.46 M in cash with (45.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 16.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |